Selective modulation of IFN-gamma mRNA stability by IL-12/NKSF.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 7994750)

Published in Cell Immunol on December 01, 1994

Authors

E Nagy1, J E Buhlmann, T Henics, M Waugh, W F Rigby

Author Affiliations

1: Department of Medicine, Dartmouth Medical School, Lebanon, New Hampshire 03756.

Articles by these authors

Signal transduction cascades regulating fungal development and virulence. Microbiol Mol Biol Rev (2000) 5.49

Immune regulation by CD40 and its ligand GP39. Annu Rev Immunol (1996) 3.56

Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE)). Ann Rheum Dis (2010) 2.68

Association of heterogeneous nuclear ribonucleoprotein A1 and C proteins with reiterated AUUUA sequences. J Biol Chem (1993) 2.57

Glyceraldehyde-3-phosphate dehydrogenase selectively binds AU-rich RNA in the NAD(+)-binding region (Rossmann fold). J Biol Chem (1995) 2.46

Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). J Clin Invest (1984) 2.43

Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J Clin Invest (1987) 2.12

Induction of MHC class II on human polymorphonuclear neutrophils by granulocyte/macrophage colony-stimulating factor, IFN-gamma, and IL-3. J Immunol (1993) 2.03

Ox40-ligand has a critical costimulatory role in dendritic cell:T cell interactions. Immunity (1999) 2.02

Hepatitis B antigen and antibody in a male homosexual population. Br J Vener Dis (1977) 1.98

Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial. Ann Rheum Dis (2010) 1.90

Syphilis as a cause of backache. Br Med J (1972) 1.55

Sexually transmitted diseases and prostitution. J R Soc Med (1989) 1.52

Cloning of mouse Ox40: a T cell activation marker that may mediate T-B cell interactions. J Immunol (1993) 1.51

Modulation of AUUUA response element binding by heterogeneous nuclear ribonucleoprotein A1 in human T lymphocytes. The roles of cytoplasmic location, transcription, and phosphorylation. J Biol Chem (1997) 1.50

The RGG domain in hnRNP A2 affects subcellular localization. Exp Cell Res (2000) 1.50

Mutations in the WRN gene in mice accelerate mortality in a p53-null background. Mol Cell Biol (2000) 1.48

A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens. J Immunol Methods (1999) 1.46

Status dystonicus and Hallervorden-Spatz disease: treatment with intrathecal baclofen and pallidotomy. J Paediatr Child Health (2004) 1.45

Enhanced stability of interleukin-2 mRNA in MLA 144 cells. Possible role of cytoplasmic AU-rich sequence-binding proteins. J Biol Chem (1994) 1.42

The immunobiology of vitamin D. Immunol Today (1988) 1.25

hnRNP A2 and hnRNP L bind the 3'UTR of glucose transporter 1 mRNA and exist as a complex in vivo. Biochem Biophys Res Commun (1999) 1.19

Nonsense-mediated decay of mRNA for the selenoprotein phospholipid hydroperoxide glutathione peroxidase is detectable in cultured cells but masked or inhibited in rat tissues. Mol Biol Cell (2001) 1.18

Identification of the NAD(+)-binding fold of glyceraldehyde-3-phosphate dehydrogenase as a novel RNA-binding domain. Biochem Biophys Res Commun (2000) 1.10

The effects of 1,25-dihydroxyvitamin D3 on human T lymphocyte activation and proliferation: a cell cycle analysis. J Immunol (1985) 1.07

Regulation of human monocyte HLA-DR and CD4 antigen expression, and antigen presentation by 1,25-dihydroxyvitamin D3. Blood (1990) 1.06

Conscious sedation or general anaesthetic for intramuscular botulinum toxin injections in children - a two centre cross-sectional prospective audit. Eur J Paediatr Neurol (2011) 1.06

Virus-like particles associated with a faecal antigen from hepatitis patients and with Australia antigen. Aust J Exp Biol Med Sci (1971) 1.05

Modulation of class I HLA antigens on HL-60 promyelocytic leukemia cells by serum-free medium: re-induction by gamma-IFN and 1,25-dihydroxyvitamin D3 (calcitriol). J Immunol (1984) 1.05

Characterization of the mRNA ligands bound by the RNA binding protein hnRNP A2 utilizing a novel in vivo technique. Nucleic Acids Res (2000) 1.02

Differentiation of a human monocytic cell line by 1,25-dihydroxyvitamin D3 (calcitriol): a morphologic, phenotypic, and functional analysis. Blood (1984) 1.01

Release of prostaglandin E2 by microfilariae of Wuchereria bancrofti and Brugia malayi. Am J Trop Med Hyg (1992) 1.01

Analysis of sequence-specific binding of RNA to Hsp70 and its various homologs indicates the involvement of N- and C-terminal interactions. RNA (2001) 0.97

The von Hippel-Lindau protein interacts with heteronuclear ribonucleoprotein a2 and regulates its expression. J Biol Chem (2001) 0.95

1 alpha,25-dihydroxyvitamin D3 inhibits productive infection of human monocytes by HIV-1. Biochem Biophys Res Commun (1991) 0.95

Specific binding of lipocortin-1 (annexin I) to monocytes and neutrophils is decreased in rheumatoid arthritis. Arthritis Rheum (1992) 0.94

Comparison of the effects of 1,25-dihydroxyvitamin D3 on T lymphocyte subpopulations. Eur J Immunol (1987) 0.90

Condylomata acuminata. Br Med J (1972) 0.90

The effects of recombinant-DNA-derived interferons on the growth of myeloid progenitor cells. Blood (1985) 0.89

The Genome Sequence DataBase (GSDB): improving data quality and data access. Nucleic Acids Res (1998) 0.87

High resolution brain SPECT imaging of marijuana smokers with AD/HD. J Psychoactive Drugs (1998) 0.83

1,25-Dihydroxyvitamin D3 induces a myelomonocytic phenotype with enhanced effector cell function in the HL-60 promyelocytic leukemia cell line. Mol Immunol (1985) 0.82

IgA-mediated effector function of HL-60 cells following treatment with calcitriol. Mol Immunol (1986) 0.81

Pharmacokinetic-pharmacodynamic relationships of the bispecific antibody MDX-H210 when administered in combination with interferon gamma: a multiple-dose phase-I study in patients with advanced cancer which overexpresses HER-2/neu. J Immunol Methods (2001) 0.80

Dopamine--adaptive uptake changes in striatal synaptosomes after 30 sec of shock-induced fighting. Biochem Pharmacol (1976) 0.79

Effect of social drinking on neuropsychological performance. Br J Addict (1989) 0.78

Microbe-Mediated Germination of Ascospores of Monosporascus cannonballus. Phytopathology (2000) 0.77

Amyl nitrite as a sexual stimulant. Br Med J (1979) 0.77

Novel regulation of an MHC class I gene response to interferon-gamma. Cell Immunol (1993) 0.75

Historical developments in gay health and medicine. Int J STD AIDS (1996) 0.75

Combined application of in vivo UV-crosslinking and in vitro label transfer in the examination of AU-rich sequence binding protein-RNA interactions. Cell Biol Int (1995) 0.75

International Union Against the Venereal Diseases and the Treponematoses: an overview. Int J STD AIDS (1995) 0.75

A global review of HIV infection, its interaction with other infections, and establishment responses. Med Leg J (2000) 0.75

The British Co-operative Clinical Group (BCCG) Sex Transm Infect (2000) 0.75

Distribution profile and in vivo RNA association of cytoplasmic AU-rich sequence binding proteins in various mammalian cells: effect of the organizational state of cellular architecture. Physiol Chem Phys Med NMR (1998) 0.75

A patient-centered orientation program. Hospitals (1974) 0.75

Autografting followed by rituximab for chemosensitive mantle cell lymphoma: a pilot study and literature review. Leuk Lymphoma (2005) 0.75

Sympathoadrenal and renin-angiotensin systems in the development of two-kidney, one clip renal hypertension in rats. Hypertension (1981) 0.75